Medical device company ResMed announced a victory in a patent infringement action against Chinese medical device manufacturer BMC Medical Co. Ltd.
The International Trade Commission ruled that some BMC’s masks infringe ResMed’s patents, and it entered an order prohibiting BMC from importing, advertising, or selling these masks in the United States, according to ResMed.
“We are pleased the court has validated ResMed’s intellectual property rights protecting those valuable innovations for the benefit of patients,” said David Pendarvis, ResMed’s chief administrative officer and global general counsel.
In its ruling, the ITC also sustained a BMC challenge to the one patent that ResMed asserted in this case against the BMC humidifier. ResMed will appeal the commission’s order on that patent and is considering further actions, the company said.
According to ResMed, which designs and makes devices for treating sleep-disordered breathing, it has a portfolio of more than 5000 patents, pending patent applications and protected designs on flow generators, humidifiers and masks relating to CPAP therapy.